Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Palisade Bio, Inc. (NASDAQ: PALI) director Robert Baltera Jr. recently increased his ownership stake in the biotechnology company through a series of stock purchases. The acquisition coincides with the company receiving FDA clearance to initiate a Phase 2 clinical trial for its investigational drug, PALI-2108, aimed at treating ulcerative colitis.
Sight Sciences, Inc. (NASDAQ:SGHT) Chief Technology Officer David Badawi completed a transaction on July 6, 2026, selling 7,418 shares of common stock valued at $40,858. The sale was facilitated through a pre-arranged Rule 10b5-1 trading plan to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). Following the transact…
Brenton Taylor, Sight Sciences' Executive Vice President of Operations and R&D, executed a sale of company shares on July 1, 2026, to cover tax liabilities related to restricted stock unit vesting. The transaction involved 2,829 shares at a weighted average price of $5.42, reducing his direct holdings but leaving him with a significant remaining st…
Jeremy B. Hayden, Sight Sciences, Inc.'s (NASDAQ:SGHT) Chief Legal Officer, executed a sale of 12,733 shares on July 6, 2026, totaling $70,133. The transaction, designated to cover tax liabilities from restricted stock unit vesting, leaves Hayden with a direct holding of 357,037 shares. This sale occurs against a backdrop of mixed first-quarter 202…
Sight Sciences, Inc. (NASDAQ: SGHT) Chief Financial Officer James Rodberg executed a sale of 6,902 common shares on July 2, 2026, totaling $36,994. The transaction, driven by tax obligations from restricted stock unit vesting, leaves Rodberg with a direct holding of 224,037 shares. This corporate activity unfolds against a backdrop of mixed first-q…
Andrew Guggenhime, who serves as both President and Chief Financial Officer at Vaxcyte, Inc. (NASDAQ: PCVX), has executed the sale of 10,000 shares of the company's common stock. The transactions, which totaled approximately $572,836, were carried out on July 6, 2026, under the parameters of a Rule 10b5-1 trading plan established earlier in the yea…
Sight Sciences President and CEO Paul Badawi executed a sale of 28,684 shares on July 1, 2026, generating $155,467 to address tax liabilities associated with restricted stock unit vesting. The transaction occurs amid the company's Q1 2026 financial results, which showed revenue growth but continued losses. Badawi retains significant ownership, hold…
Alison Bauerlein, Chief Operating Officer of Sight Sciences, Inc. (NASDAQ: SGHT), executed a sale of 24,184 shares on July 2, 2026, generating approximately $129,626 in proceeds. The transaction was structured to cover tax liabilities tied to the vesting of restricted stock units. Following the sale, Bauerlein retains direct ownership of 664,709 sh…
Bruce K. Posey, the Chief Legal Officer at Qualys, Inc. (NASDAQ:QLYS), executed a sale of 1,000 shares on July 6, 2026, totaling $155,000. This transaction follows a pre-arranged Rule 10b5-1 trading plan. The sale occurs as QLYS stock trades near its 52-week high, reflecting a complex landscape of analyst opinions and corporate developments in the …
Francis Lo, Chief People Officer at Adaptive Biotechnologies Corp (NASDAQ:ADPT), executed a series of transactions involving the sale and acquisition of company stock in early July 2026. The executive's dispositions were carried out under a pre-established Rule 10b5-1 trading plan, occurring as the stock trades near its 52-week high. Concurrently, …
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Chief Commercial Officer Susan Bobulsky executed a stock sale on July 1, 2026, disposing of 487 shares at $22.00 each under a pre-existing Rule 10b5-1 plan. The transaction follows a period of significant price appreciation for ADPT, which recently traded near its 52-week high of $22.80. This insider act…
Qualys, Inc. (NASDAQ:QLYS) reported that Chief Financial Officer Kim Joo Mi executed a stock sale worth $138,419 on July 2, 2026, under a pre-established Rule 10b5-1 trading plan. The transaction involved 965 shares at $143.44 per share, leaving Ms. Kim with a direct holding of 81,215 shares. Recent corporate updates include the TotalCloud solution…
Symbotic Inc. (NASDAQ:SYM) Director Charles Kane executed a sale of 2,000 Class A Common Stock shares on July 1, 2026, generating $89,800 through a 10b5-1 trading plan. The transaction involved redeeming Symbotic Holdings Units, which were subsequently canceled. This move occurs against a backdrop of recent stock depreciation and mixed Q2 fiscal 20…
William M. Boyd III, Chief Strategy Officer at Symbotic Inc. (NASDAQ:SYM), executed a sale of 5,115 shares of the company’s Class A Common Stock on July 1, 2026, generating approximately $230,959 in proceeds. The transaction was conducted under a pre-arranged 10b5-1 trading plan established on August 19, 2025. Following the sale, Boyd retains direc…
April S. Arnzen, Executive Vice President and Chief People Officer at Micron Technology Inc. (NASDAQ: MU), executed a significant divestment of company equity on July 1, 2026. The transaction involved the sale of 40,000 common shares, generating proceeds totaling $43,357,473. These sales were conducted within the parameters of a Rule 10b5-1 trading…
John Daunt, Executive Vice President and Chief Commercial Officer at Liquidity Services Inc. (NASDAQ:LQDT), executed a sale of 462 shares on July 1, 2026. The transaction involved exercising stock options and immediately selling the acquired shares through The Daunt Family Trust. This activity follows a period of significant stock appreciation and …
Mark Hancock, a director and substantial shareholder in PACS Group Inc., executed a series of stock sales totaling approximately $7.3 million earlier this month. The transactions were facilitated through a Rule 10b5-1 trading plan established in March 2026. This financial activity occurs against a backdrop of significant stock appreciation and rece…
Michelle Renee Lewis, serving as the Chief Accounting Officer at PACS Group, Inc. (NASDAQ:PACS), has executed a series of stock sales totaling 15,000 shares. The transactions, valued at approximately $675,424, were carried out in early July 2026 under a Rule 10b5-1 trading plan established in March of that year. This executive activity occurs again…
Walter S. Woltosz, a director and 10% owner of Simulations Plus, Inc. (NASDAQ:SLP), along with Virginia E. Woltosz, also a 10% owner, executed a sale of 4,177 shares of the company’s common stock on July 1, 2026. The transactions, valued at $77,023, were conducted at prices between $18.36 and $18.49 per share. The sale followed a Rule 10b5-1 tradin…
Ionis Pharmaceuticals (NASDAQ: IONS) Director Joseph Klein III sold 11,518 shares of the company's common stock on July 1, 2026, realizing approximately $910,416 in proceeds. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan established on November 25, 2025. Prior to the sale, Mr. Klein exercised non-qualified stock option…
Everspin Technologies Inc. (NASDAQ: MRAM) Vice President of Sales, Sean Michael Dougherty, executed a sale of company stock on July 1, 2026, to meet tax liabilities associated with the vesting of Restricted Stock Units. This transaction occurs against a backdrop of substantial recent corporate developments, including a major $40 million defense con…
Sanjeev Aggarwal, President and CEO of Everspin Technologies, executed a sale of 30,885 shares on July 1, 2026, generating $689,970 to cover tax liabilities from Restricted Stock Unit vesting. The transaction leaves him with 839,561 directly held shares. This financial move occurs against a backdrop of significant corporate developments, including …
Gregory Bowles, chief policy officer at Joby Aviation, Inc. (NASDAQ: JOBY), executed two distinct transactions in early July 2026, liquidating a total of 9,882 shares of the company's common stock for a combined value of $88,997. These sales occurred against a backdrop of significant stock price volatility, with JOBY trading at $8.93, representing …
Bonny Simi, President of Operations at Joby Aviation, Inc. (NASDAQ:JOBY), executed a sale of 7,832 shares on July 2, 2026, generating $69,861. The transaction, priced at $8.92 per share, was facilitated to satisfy tax obligations arising from the vesting of restricted stock units. This event occurs against a backdrop of significant stock volatility…
Joby Aviation CFO Rodrigo Brumana sold $23,200 worth of stock on July 2, 2026, to cover taxes on vesting RSUs. The sale occurred as the company reported Q1 2026 revenue of $24 million against forecasts of $20.2 million, while posting a GAAP net loss of $110 million due to ongoing certification and manufacturing investments. Joby also announced a ma…
